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Background:  The hypothalamus, the center for body weight regulation, can sense changes in blood glucose level based on ATP-
sensitive potassium (KATP) channels in the hypothalamic neurons. We hypothesized that a lack of glucose sensing in the hypo-
thalamus affects the regulations of appetite and body weight. 
Methods:  To evaluate this hypothesis, the responses to glucose loading and high fat feeding for eight weeks were compared in 
Kir6.2 knock-out (KO) mice and control C57BL/6 mice, because Kir6.2 is a key component of the KATP channel.
Results:  The hypothalamic neuropeptide Y (NPY) analyzed one hour after glucose injection was suppressed in C57BL/6 mice, 
but not in Kir6.2 KO mice, suggesting a blunted hypothalamic response to glucose in Kir6.2 KO mice. The hypothalamic NPY 
expression at a fed state was elevated in Kir6.2 KO mice and was accompanied with hyperphagia. However, the retroperitoneal 
fat mass was markedly decreased in Kir6.2 KO mice compared to that in C57BL/6 mice. Moreover, the body weight and visceral 
fat following eight weeks of high fat feeding in Kir6.2 KO mice were not significantly different from those in control diet-fed Kir6.2 
KO mice, while body weight and visceral fat mass were elevated due to high fat feeding in C57BL/6 mice. 
Conclusion:  These results suggested that Kir6.2 KO mice showed a blunted hypothalamic response to glucose loading and ele-
vated hypothalamic NPY expression accompanied with hyperphagia, while visceral fat mass was decreased, suggesting resistance 
to diet-induced obesity. Further study is needed to explain this phenomenon.
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INTRODUCTION
Obesity is a condition characterized by excessive accumula-
tion of fat in the body resulting from a chronic excess energy 
intake compared to energy expenditure. Currently, obesity is 
considered a disease state because it is associated with meta-
bolic syndrome, including diabetes, hypertension, atheroscle-
rosis, dyslipidemia, and hyperuricemia. Moreover, obesity has 
dramatically increased throughout the world [1]. Body weight 
homeostasis is maintained through the balance between ener-
gy expenditure and energy intake, and these processes are con-
trolled in the hypothalamus - the center for body weight regu-
lation. Various mechanical and hormonal signals from the gut 
and adipose tissue, such as gut distension, leptin, insulin, glu-
cagon-like peptide 1, cholecystokinin, peptide YY, pancreatic 
polypeptide, oxyntomodulin and ghrelin, etc., stimulate proo-
piomelanocortin (POMC; the precursor of a melanocyte-stim-
ulating hormone) and cocaine- and amphetamine-regulated 
transcript (CART) expressing neurons or neuropeptide Y (NPY) 
and agouti-related peptide (AgRP) expressing neuron in the 
arcuate nucleus of the hypothalamus. POMC and CART are 
typical anorexigenic peptides, while NPY and AgRP are typi-
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cal orexigenic peptides [2-4]. When anorexigenic peptide is 
elevated, melanocortin receptor 3/4 in the paraventricular nu-
cleus of the hypothalamus is activated and satiation and ther-
mogenesis are induced. Increased orexigenic peptide activates 
the Y1/5 receptor in the paraventricular nucleus of the hypo-
thalamus, induces a sense of hunger, and halts thermogenesis 
[5]. 
  In addition to the mechanical and hormonal signals enter-
ing the hypothalamus, the hypothalamic neurons also directly 
sense nutrient signals in the blood, such as hyperglycemia and 
hyperlipidemia, and activate the regulatory processes of ener-
gy balance in the hypothalamus [6]. There are specialized sub-
groups of hypothalamic neurons which sense the changes in 
blood glucose levels [7,8]. Glucose-sensing neurons were as-
sumed to employ the glucose-sensing strategy used in pancre-
atic β-cells, where increased intracellular glucose, resulted 
from hyperglycemia, increases cytosolic ATP through glucose 
metabolism. This leads to closure of ATP-sensitive potassium 
ion channels (KATP channels) containing Kir6.x potassium 
channel subunits and sulfonylurea receptors, causing mem-
brane depolarization, Ca
++ influx, and insulin release or in-
creased excitability [9]. Metabolic stresses such as hypoxia, 
ischemia, or hypoglycemia lead to depletion of intracellular 
ATP and activation of KATP channels, resulting in hyperpolar-
ization and decreased excitability. The KATP channels are ex-
pressed not only in pancreatic β-cells, but also in cardiac mus-
cle and neurons in the hypothalamus and brain stem [10-12]. 
Activation of the neuronal KATP channels during depletion of 
ATP hyperpolarizes the neuron membrane, thereby reducing 
neuronal excitability and ATP consumption.
  Recently, there has been accumulating evidence that KATP 
channels are associated with regulation of food intake. The ex-
pression of the KATP channel component, Kir6.2, was decreased 
in the dorsomedial and ventromedial hypothalamus of Zucker 
diabetic fatty rats [13]. Polakof et al. [14] reported that intra-
cerebroventricular injection of glucose or deoxyglucose chan-
ges appetite via glucose-sensing components in the hypothala-
mus of rainbow trout. Jo et al. [15] demonstrated that oleic 
acid increased POMC expression through suppression of the 
KATP channel in the hypothalamus. However, we do not yet 
know how KATP channel activity is associated with the regula-
tion of food intake. 
  In this study, we evaluated the role of hypothalamic KATP 
channels in the regulations of appetite and body weight using 
Kir6.2 knock-out (KO) mice and control C57BL/6 mice be-
cause Kir6.2 is a key component of the KATP channel. 
METHODS
Animal care
Male KATP KO mice and C57BL/6 control mice were used in 
this study. Kir6.2 subunit KO mice were kindly donated by Dr. 
S. Seino at Kobe University, and C57BL/6 mice were purchased 
from Jung-Ang Experimental Animals (Seoul, Korea). The 
mice were housed individually with a 12:12 light:dark cycle 
(07:00 to 19:00 hour) and were cared for in accordance with 
the “Guide to the Care and Use of Experimental Animals” of 
the Yeungnam Medical Center. This experimental protocol 
was approved by the Ethics Committee of Yeungnam Univer-
sity.
Experimental design
Experiment 1
To analyze whether Kir6.2 deletion affects glucose-sensing in 
the hypothalamus, a 20% glucose solution (2 g/kg) was inject-
ed intraperitoneally into 12-week-old Kir6.2 KO and C57BL/6 
mice. One hour after the injection, blood was collected through 
the abdominal aorta, and the hypothalamus was excised and 
analyzed for hypothalamic neuropeptides.
Experiment 2
To evaluate the role of Kir6.2 on the induction of obesity, four-
week-old Kir6.2 KO mice and C57BL/6 mice were treated with 
a high fat diet or control diet for eight weeks. Food intake and 
body weight were measured twice per week. After eight weeks 
of high fat or control diet, blood samples were obtained and 
visceral fat and the hypothalamus were removed. The diets 
used in this study were the ‘HFD60%cal’ high fat diet and the 
‘AIN93G’ control diet. The ‘HFD60%cal’ was composed of 
protein, carbohydrate, and fat (20, 20, and 60%, respectively, of 
total calories) supplemented with vitamins (1%) and minerals 
(3.5%), while the caloric composition of ‘AIN93G’ was 20, 64, 
and 16% (protein, carbohydrate, and fat, respectively). The di-
ets were provided by Feedlab Korea Co. (Seoul, Korea). 
Tissue preparations
Mice were anesthetized via intraperitoneal injection of Tilet-
amine and Zolazepam (25 mg/kg BW, Zoletil®; Virbac, Carros, 
France). Blood was rapidly collected through the abdominal 
aorta using a heparin coated syringe and then separated from 221
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plasma using centrifugation at 4°C. Visceral fat tissues in peri-
renal, retroperitoneal and epididymal areas were excised and 
weighed. The hypothalamus was excised, quickly frozen in liq-
uid nitrogen, and stored in a deep freezer.
Real time polymerase chain reaction analysis
Each whole mouse hypothalamus was homogenized in TRI 
reagent (Sigma-Aldrich, St. Louis, MO, USA) using an Ultra-
Turrax T25 (Staufel, Germany). RNA was reverse transcribed 
to cDNA from 1 μg of total RNA using a High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, Foster City, 
CA, USA). Quantitative real-time PCR was performed using 
the Real-Time PCR 7500 system and Power SYBR Green PCR 
master mix (Applied Biosystems), according to the manufac-
turer’s instructions. The expression level of glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) was used as an inter-
nal control. The reactions were incubated at 95°C for 10 min-
utes, followed by 45 cycles of 95°C for 15 seconds, 55°C for 20 
seconds, and 72°C for 35 seconds. Primers for mouse POMC, 
NPY, and GAPDH were based on NCBI’s nucleotide database 
and designed using the Primer Express program (Applied Bio-
systems): mouse POMC (forward, 5´-ACC TCA CCA CGG 
AAA GCA A-3´; reverse, 5´-CGG GGA TTT TCA GTA AAG 
G-3´), mouse NPY (forward, 5´-TAT CCC TGC TCG TGT 
GTT TG-3´; reverse, 5´-GTT CTG GGG GCA TTT TCT G-3´), 
mouse GAPDH (forward, 5´-CAG GAT GAC ACC AAA ACC 
CTC-3´; reverse, 5´-TCC AAG CCA GTG ACC CTC TG-3´).
Statistical analysis
The data was expressed as mean±standard error. Statistical 
comparisons between control and Kir6.2-deficient mice were 
made using the t-test. A value of less than 0.05 was considered 
statistically significant. 
RESULTS
Responses to glucose loading in Kir6.2 KO mice
Overnight fasting glucose levels in C57BL/6 and Kir6.2 KO 
mice were not significantly different. Serum glucose levels were 
significantly elevated at one hour after glucose injection (2 g/
kg) in both C57BL/6 and Kir6.2 KO mice (Fig. 1A). The hypo-
thalamic neuropeptides were analyzed one hour after glucose 
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Fig. 1. The serum glucose levels (A) and hypothalamic expres-
sions of proopiomelanocortin (POMC; B) and neuropeptide Y 
(NPY; C) mRNA following intraperitoneal saline or glucose 
injection in overnight fasted C57BL/6 and Kir6.2 knockout 
(KO) mice. Values are the mean±standard error of 5 to 10 ex-
perimental animals per group. 
aP<0.05 vs. the saline group.222
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injection and there was no significant difference in basal hy-
pothalamic POMC or NPY expression between C57BL/6 and 
Kir6.2 KO mice. However, the hypothalamic NPY expression 
was significantly decreased by glucose injection in C57BL/6 
mice, while there was no change in Kir6.2 KO mice, suggest-
ing a failure of the hypothalamic glucose sensing function (Fig. 
1B and C).
Characteristics of Kir6.2 KO mice and response to a high 
fat diet
The body weights of Kir6.2 KO mice were not significantly dif-
ferent from those of age matched C57BL/6 mice (Table 1, ini-
tial body weight), while daily caloric intake was higher in Kir6.2 
KO mice (Fig. 2A). Interestingly, the retroperitoneal white adi-
pose tissue (RT-WAT) deposition was dramatically decreased 
in Kir6.2 KO mice compared to that in C57BL/6 mice (Fig. 
2B). The eight-week high fat diet significantly increased body 
weight compared to that of the control diet in C57BL/6 mice, 
while the body weight of eight-week high fat-treated Kir6.2 
KO mice was not increased compared to that of control diet-
ing mice. RT-WAT mass changes following a high fat diet also 
showed the same pattern as did body weight changes. The in-
crease in RT-WAT mass following a high fat diet in Kir6.2 KO 
mice was less than that in C57BL/6 mice (Fig. 2B). 
  Serum glucose levels did not differ between C57BL/6 and 
Kir6.2 KO mice, while serum concentrations of FFA, insulin, 
and leptin were significantly lower in Kir6.2 KO mice com-
pared to those in C57BL/6 mice. Moreover, there were no sig-
nificant changes in serum glucose, FFA, insulin or leptin fol-
lowing eight weeks of a high fat diet in Kir6.2 KO mice, while 
there were significant elevations in insulin and leptin in C57-
BL/6 mice (Fig. 3). The hypothalamic NPY mRNA expression 
at the “fed state” was elevated in Kir6.2 KO mice compared to 
that in C57BL/6 mice; however, there was no significant change 
following a high fat diet in either C57BL/6 or Kir6.2 KO mice 
(Fig. 3F). The hypothalamic POMC mRNA expressions were 
not different among the experimental groups (Fig. 3E). 
DISCUSSION
In the present study, we measured hypothalamic expressions 
of POMC and NPY, caloric intake, body weight, and visceral 
fat mass following eight weeks of high fat dieting in Kir6.2 KO 
mice and control C57BL/6 mice to investigate the role of the 
KATP channel in the regulation of food intake and the induc-
Table 1. Changes in body weight following a control or high fat 
diet in the experimental animals
Diet
C57BL/6 Kir6.2 KO
Control High fat Control High fat
Body weight, g
   Initial  18.8±0.41 18.8±0.26 17.8±0.56 17.7±0.50
   Final  31.9±1.59 37.2±1.08
a 28.2±1.45 28.6±1.05
   Wt. gain 13.1±6.55 18.4±9.20
a 10.4±5.18 10.9±5.46
   N 5 5 8 10
Data are presented as mean±standard error of the experimental ani-
mals. N indicates the number of experimental cases. 
aP<0.05 vs. C57BL/6 controls.
Fig. 2. The average daily caloric intake (A) and deposition of retroperitoneal white adipose tissue (RT-WAT; B) in control or high 
fat diet-fed C57BL/6 (normal) and Kir6.2-deficient (KO) mice. Values are the mean±standard error of 5 to 10 experimental ani-
mals per group. N-C, normal control group; N-HF, high fat-fed normal mice; KO-C, control diet fed Kir6.2 KO mice; KO-HF, 
high fat diet-fed Kir6.2 KO mice. 
aP<0.05 vs. N-C, 
bP<0.05 vs. KO-C. 
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tion of obesity. This study demonstrated that Kir6.2-deficient 
mice showed increased hypothalamic NPY expression accom-
panied with increased caloric intake, decreased visceral fat 
mass, and resistance to the induction of obesity by a high fat 
diet compared to the levels in C57BL/6 mice. 
  KATP channels were first identified in the heart and have been 
extensively studied in both cardiac myocytes and pancreatic 
β-cells [16-18]. Deletion of KATP channels due to disruption of 
the Kir6.2 gene results in the complete absence of KATP channel 
activity in pancreatic β-cells, skeletal muscle, and heart [19]. 
In this study, we focused on the role of KATP channels in the 
hypothalamus - a regulatory center for body weight homeo-
stasis. Several previous reports have provided evidence for an 
association of the hypothalamic KATP channel with obesity or 
appetite regulation [13-15,20]. We also found that hypotha-
lamic Kir6.2 mRNA expression increased in high fat, obese 
mice (data not shown), which is inconsistent with the report 
by Gyte et al. [13] that showed reduced expression of Kir6.2 in 
the hypothalami of Zucker diabetic fatty rats. 
  This discrepancy might result from differences in the ani-
mal models used for the study. The increase in Kir6.2 expres-
sion in high fat-fed mice appears to result from a compensato-
ry mechanism. In the present study, we found that an absence 
of a glucose-sensing mechanism in the hypothalamic neurons 
leads to a blunted satiety signal, while C57BL/6 mice showed a 
decrease in hypothalamic NPY, an orexigenic neuropeptide 
(Fig. 1C). Moreover, Kir6.2 KO mice demonstrated hyperpha-
gia and increased hypothalamic NPY mRNA expression in the 
fed state (Figs 2A and 3F). We suggested that these results are 
associated with the co-localization of Kir6.2 and NPY throug-
hout the hypothalamus [13,21,22]. The hypothalamus con-
tains glucose-inhibited neurons and glucose-excited neurons 
[23]. The NPY neuron is a typical glucose-inhibited neuron 
[21], while the POMC neuron is a typical glucose-excited neu-
ron [12]. Thus, in the present study, glucose loading induced 
the suppression of hypothalamic NPY mRNA expression in 
C57BL/6 mice. 
  Although there are several reports demonstrating the invol-
Fig. 3. The serum levels of glucose (A), free fatty acids (FFA; B), insulin (C), and leptin (D), and the hypothalamic expressions of 
proopiomelanocortin (POMC; E) and neuropeptide Y (NPY; F) mRNA in control or high fat diet-fed C57BL/6 (normal) and 
Kir6.2-deficient (KO) mice. Values are the mean±standard error of 5 to 10 experimental animals per group. N-C, normal con-
trol group; N-HF, high fat-fed normal mice; KO-C, control diet-fed Kir6.2 KO mice; KO-HF, high fat diet-fed Kir6.2 KO mice. 
aP<0.05 vs. N-C.
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vement of POMC neurons in glucose-sensing [12,20,24], we 
did not observe any changes in hypothalamic POMC mRNA 
expression in either C57BL/6 or Kir6.2 KO mice (Fig. 1B). This 
result is supported by Fioramonti et al.’s study [21] showing 
that more than 95% of POMC neurons do not respond to glu-
cose in vitro. The Kir6.2 KO mice showed normoglycemia and 
mild glucose intolerance (data not shown) in fasting and feed-
ing states (Figs 1A and 3A), while serum insulin concentration 
was decreased compared to the levels in C57BL/6 mice. These 
results are consistent with previous reports [19,25] in that Kir-
6.2-deficient mice demonstrated only mild glucose intolerance, 
despite the marked defect in insulin secretion. The maintenan-
ce of a normoglycemic condition in Kir6.2 KO mice might re-
sult from enhanced insulin sensitivity in skeletal muscle [25,26]. 
Serum levels of leptin and FFA were markedly decreased in 
Kir6.2 KO mice compared to those in C57BL/6 mice (Fig. 3), 
which resulted from the decrease in body fat mass.
  Although Kir6.2 KO mice showed a blunted satiety signal to 
glucose injection and hyperphagia, visceral fat mass was mark-
edly decreased and resistant to induction of obesity due to a 
high fat diet in this study. These results are consistent with Ale-
kseev et al.’s recent study [27] showing that genetic disruption 
of the KATP channel function results in a lean phenotype that is 
resistant to diet-induced obesity. They demonstrated an in-
crease in energy expenditure in cardiac and skeletal muscles in 
the Kir6.2 KO mice, which may result in the lean phenotype. 
However, they also demonstrated that the running distance of 
Kir6.2 KO mice was lower than that of wild-type mice, which 
is supported by our unpublished data. We found that oxygen 
consumption corrected according to running distance was in-
creased in Kir6.2 KO mice (data not shown), suggesting a low-
er fuel efficiency during exercise, which may result in the lean 
phenotype by magnifying the benefit of activity [28]. However, 
why Kir6.2 KO mice have such a lean phenotype despite show-
ing hyperphagia and lowered locomotor activity could not be 
explained completely, even though Kir6.2 KO mice have an 
inefficient energy expending system. 
  The limitation of this study is that Kir6.2 KO effects are not 
specific for the hypothalamus because Kir6.2 mRNA is expre-
ssed not only in neurons, but in most excitable tissues such as 
pancreatic β-cells, cardiac muscle, and skeletal muscle [19,23]. 
Although the glucose-sensing role of the hypothalamic KATP 
channels was demonstrated by the blunted hypothalamic re-
sponse to glucose loading and hyperphagia, the effects of Kir-
6.2 KO on pancreatic β-cells, cardiac muscle, and skeletal mus-
cle affected the results of this experiment. To eliminate the ex-
tra-hypothalamic effects, further studies using selective dele-
tion of hypothalamic Kir6.2 are needed. Although we could 
not explain the exact mechanism for the lean phenotype in 
Kir6.2 KO mice, the development of an animal model resistant 
to obesity induction may lead to obesity treatment.
  In summary, Kir6.2 KO mice showed a blunted hypotha-
lamic response to glucose loading, increased hypothalamic 
NPY expression associated with hyperphagia, smaller visceral 
fat mass, and resistance to induction of obesity due to a high 
fat diet. We could not completely explain the disparity between 
hyperphagia and smaller visceral fat mass. Further study is 
need  ed to define the mechanism explaining this phenomenon.
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